Kaufmann WE, Worley PF, Pegg J, Bremer M, Isakson P (1996) COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex
For treatment of T2D amongst patients without pre-existing cardiovascular or renal complications who are not adequately controlled on metformin (with or without sulfonylurea), in order to reduce HbA1c levels, international [13] and Danish [14] guidelines recommend intensifying with anti-diabetic treatment options such as dipeptidyl peptidase-4 inhibitors (DPP4is), sodiumglucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide 1 receptor agonists (GLP-1RAs)
GCe: Writing review & editing
Patients diagnosed with gastroparesis are now coming forward and filing Ozempic GLP-1 gastroparesis injury lawsuits seeking compensation and justice for the harm and suffering they may have endured
We selected post-market real-world data of individual GLP-1 RAs for analysis, although this approach provides a more accurate description of the characteristics of each GLP-1 RA, it does not allow us to evaluate the overall intensity and magnitude of targeting a specific drug with disproportionate signaling effects
